Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives. However ...

A newly discovered genetic clock acts as the master timekeeper for development, orchestrating crucial bursts of gene activity ...

Google senior AI product manager Shubham Saboo has turned one of the thorniest problems in agent design into an open-source engineering exercise: persistent memory. This week, he published an ...

Neuroscientist Kevin Hellman initially came to Endeavor Health’s Evanston Hospital to research chronic pain in the brain stem. In 2013, he collaborated with researchers from the Gynecology Research ...

“It’s complicated because cannabis products are complicated,” said lead author of the study, Roger Chou, M.D., senior adviser for the Pacific Northwest Evidence-based Practice Center at Oregon Health ...

Europe is failing thousands of stem-cell transplant survivors by not recognising the chronic, long-term nature of the disease that shapes their lives after transplantation, a leading specialist warns.

Bengaluru: A decade ago, Persistent Systems founder Anand Deshpande's net worth was under $200 million. Quietly riding the company's steady rise, his fortune has since surged to about $3.4 billion.

Shares of Persistent Systems were trading higher at Rs 5,281.50, marking a gain of 2.14% in today's session. The stock is a constituent of the Nifty Midcap 150. On the financial front, Persistent ...

Four in ten adults with chronic pain experience clinically significant depression and anxiety, reported a new systematic review and meta-analysis published in JAMA Network Open. "Right now, we have ...

The 2025 Los Angeles wildfires — ongoing at the time of publication — have destroyed entire communities. Many have lost loved ones, homes, schools, churches, and neighborhoods. Entire social networks ...

The share of Persistent Systems zoomed more than 11 per cent on the NSE (National Stock Exchange) after net profit and revenue saw jumps of 23 per cent and 20 per cent respectively, in the Q2 FY25.

“I know nothing about marijuana. I know that it’s not particularly dangerous. I know most of the kids are for legalizing it. But on the other hand, it’s the wrong signal at this time.” So said Richard ...